Blockchain is a new technology that has attracted a tremendous amount of interest. However, up to now, blockchain has mainly been used to develop decentralized multi-party applications. This ...presentation describes breakthrough technology that deeply integrates blockchain into the Oracle database. Since virtually all critical data are stored in databases, this makes it possible to implement blockchain in mainstream healthcare and enterprise applications with minimal changes. We will begin by introducing the threats posed by hackers and compromised insiders. Then we will describe how in-database blockchain can protect data against these threats, comparing this against conventional blockchains. Use cases are shared from customers that have adopted this technology. Learning Objectives Understand the concepts behind crypto-security and the threats it addresses Explore the challenges of the adoption of blockchain Learn how database-integrated blockchain can be used to protect critical data against tampering What are the advantages and disadvantages of a database-integrated blockchain? Get an understanding of the types of healthcare data that can be protected using blockchain
Early in 2020, China’s National Development and Reform Commission initially outlined the parameters of new infrastructure, with blockchain technology serving as a crucial tenet. A technologically ...advanced infrastructure system based on information networks, targeted at the requirements of high-quality development, and offering services like digital transformation, intelligent upgrades, and integrated innovation is what is hoped to be built. This study builds a DID model for analysis and aims to investigate how the adoption of the blockchain policy has affected the performance of various carbon emission enterprises. The paper discovered that blockchain regulation has a negative impact on the performance of high-carbon emission businesses using the DID model. A robustness assessment using PSM-DID reveals the same results. Furthermore, we found that the current ratio and ttm had a positive impact on corporate performance. This paper still has some limitations. To explore the impact of blockchain policy on the performance of various types of organizations, the article does not take into account the state-owned and non-state-owned qualities of enterprises. Future research on this topic will focus on the characteristics of businesses.
The annual ConV2X is a leading international health tech symposium driving real world evidence, strategy, research, operations and trends to create a blueprint for a new digital health era. The 2021 ...symposium featured a scientific program of academic/research presentations in addition to business and industry talks. The research track focused on exploring and sharing developments in blockchain and emerging technologies in health and clinical medicine. Submissions were based on original research, conceptual frameworks, proposed applications, position papers, case studies, and real-world implementation. Selection was based on a peer-review process. Faculty, students, and industry researchers were encouraged to submit abstracts to present ideas before an informed and knowledgeable audience of industry leaders, policy makers, funders, and researchers.This presentation was selected by the scientific review committee.Submission Review Committee* Dave Kochalko, CEO of ARTiFACTS* Anjum Khurshid, UT Austin* Carlos Caldas, UT Engineering* Gil Alterovitz, Harvard Medical School* Kayo Fujimoto, UT Health Houston* Lei Zhang, University of Glasglow* Sean Manion, CSciO of ConsenSys Health* Vijayakuman Varadarajan, University of South Wales* Vikram Dhillon, Wayne State University* Yuichi Ikeda, Kyoto University
The annual ConV2X is a leading international health tech symposium driving real world evidence, strategy, research, operations and trends to create a blueprint for a new digital health era. The 2021 ...symposium featured a scientific program of academic/research presentations in addition to business and industry talks. The research track focused on exploring and sharing developments in blockchain and emerging technologies in health and clinical medicine. Submissions were based on original research, conceptual frameworks, proposed applications, position papers, case studies, and real-world implementation. Selection was based on a peer-review process. Faculty, students, and industry researchers were encouraged to submit abstracts to present ideas before an informed and knowledgeable audience of industry leaders, policy makers, funders, and researchers.This presentation was selected by the scientific review committee.Submission Review Committee* Dave Kochalko, CEO of ARTiFACTS* Anjum Khurshid, UT Austin* Carlos Caldas, UT Engineering* Gil Alterovitz, Harvard Medical School* Kayo Fujimoto, UT Health Houston* Lei Zhang, University of Glasglow* Sean Manion, CSciO of ConsenSys Health* Vijayakuman Varadarajan, University of South Wales* Vikram Dhillon, Wayne State University* Yuichi Ikeda, Kyoto University
The annual ConV2X is a leading international health tech symposium driving real world evidence, strategy, research, operations and trends to create a blueprint for a new digital health era. The 2021 ...symposium featured a scientific program of academic/research presentations in addition to business and industry talks. The research track focused on exploring and sharing developments in blockchain and emerging technologies in health and clinical medicine. Submissions were based on original research, conceptual frameworks, proposed applications, position papers, case studies, and real-world implementation. Selection was based on a peer-review process. Faculty, students, and industry researchers were encouraged to submit abstracts to present ideas before an informed and knowledgeable audience of industry leaders, policy makers, funders, and researchers.This presentation was selected by the scientific review committee.Submission Review Committee* Dave Kochalko, CEO of ARTiFACTS* Anjum Khurshid, UT Austin* Carlos Caldas, UT Engineering* Gil Alterovitz, Harvard Medical School* Kayo Fujimoto, UT Health Houston* Lei Zhang, University of Glasglow* Sean Manion, CSciO of ConsenSys Health* Vijayakuman Varadarajan, University of South Wales* Vikram Dhillon, Wayne State University* Yuichi Ikeda, Kyoto University
The annual ConV2X is a leading international health tech symposium driving real world evidence, strategy, research, operations and trends to create a blueprint for a new digital health era. The 2021 ...symposium fetured a scientific program of academic/research presentations in addition to business and industry talks. The research track focused on exploring and sharing developments in blockchain and emerging technologies in health and clinical medicine. Submissions were based on original research, conceptual frameworks, proposed applications, position papers, case studies, and real-world implementation. Selection was based on a peer-review process. Faculty, students, and industry researchers were encouraged to submit abstracts to present ideas before an informed and knowledgeable audience of industry leaders, policy makers, funders, and researchers.This presentation was selected by the scientific reveiw committee.Submission Review Committee* Dave Kochalko, CEO of ARTiFACTS* Anjum Khurshid, UT Austin* Carlos Caldas, UT Engineering* Gil Alterovitz, Harvard Medical School* Kayo Fujimoto, UT Health Houston* Lei Zhang, University of Glasglow* Sean Manion, CSciO of ConsenSys Health* Vijayakuman Varadarajan, University of South Wales* Vikram Dhillon, Wayne State University* Yuichi Ikeda, Kyoto University
The article analyzes blockchain technology in relation to the field of legal regulation of genomic research. The key features of this technology, which allow one to consider it as one of the elements ...of the mechanism for ensuring the balance of private, group and public interests are highlighted. Examples of the use of blockchain technology in healthcare are given, and proposals of various researchers on the use of this technology in the field of genomic research are analyzed. The analysis and classification of interests in the considered sphere of social relations is carried out, factors that must be taken into account when ensuring the balance of interests are given. Authors propose an approach to the mechanism of ensuring the balance, which, according to the authors, consist of three elements. At the same time, the place of blockchain technology in the specified mechanism is determined, conclusions and approaches are proposed for using this technology to ensure a balance of private, group and public interests.
The annual ConV2X is a leading international health tech symposium driving real world evidence, strategy, research, operations and trends to create a blueprint for a new digital health era. The 2021 ...symposium featured a scientific program of academic/research presentations in addition to business and industry talks. The research track focused on exploring and sharing developments in blockchain and emerging technologies in health and clinical medicine. Submissions were based on original research, conceptual frameworks, proposed applications, position papers, case studies, and real-world implementation. Selection was based on a peer-review process. Faculty, students, and industry researchers were encouraged to submit abstracts to present ideas before an informed and knowledgeable audience of industry leaders, policy makers, funders, and researchers.This presentation was selected by the scientific review committee.Submission Review Committee* Dave Kochalko, CEO of ARTiFACTS* Anjum Khurshid, UT Austin* Carlos Caldas, UT Engineering* Gil Alterovitz, Harvard Medical School* Kayo Fujimoto, UT Health Houston* Lei Zhang, University of Glasglow* Sean Manion, CSciO of ConsenSys Health* Vijayakuman Varadarajan, University of South Wales* Vikram Dhillon, Wayne State University* Yuichi Ikeda, Kyoto University
The annual ConV2X is a leading international health tech symposium driving real world evidence, strategy, research, operations and trends to create a blueprint for a new digital health era. The 2021 ...symposium featured a scientific program of academic/research presentations in addition to business and industry talks. The research track focused on exploring and sharing developments in blockchain and emerging technologies in health and clinical medicine. Submissions were based on original research, conceptual frameworks, proposed applications, position papers, case studies, and real-world implementation. Selection was based on a peer-review process. Faculty, students, and industry researchers were encouraged to submit abstracts to present ideas before an informed and knowledgeable audience of industry leaders, policy makers, funders, and researchers.This presentation was selected by the scientific review committee.Submission Review Committee* Dave Kochalko, CEO of ARTiFACTS* Anjum Khurshid, UT Austin* Carlos Caldas, UT Engineering* Gil Alterovitz, Harvard Medical School* Kayo Fujimoto, UT Health Houston* Lei Zhang, University of Glasglow* Sean Manion, CSciO of ConsenSys Health* Vijayakuman Varadarajan, University of South Wales* Vikram Dhillon, Wayne State University* Yuichi Ikeda, Kyoto University
The annual ConV2X is a leading international health tech symposium driving real world evidence, strategy, research, operations and trends to create a blueprint for a new digital health era. The 2021 ...symposium featured a scientific program of academic/research presentations in addition to business and industry talks. The research track focused on exploring and sharing developments in blockchain and emerging technologies in health and clinical medicine. Submissions were based on original research, conceptual frameworks, proposed applications, position papers, case studies, and real-world implementation. Selection was based on a peer-review process. Faculty, students, and industry researchers were encouraged to submit abstracts to present ideas before an informed and knowledgeable audience of industry leaders, policy makers, funders, and researchers.This presentation was selected by the scientific review committee.Submission Review Committee* Dave Kochalko, CEO of ARTiFACTS* Anjum Khurshid, UT Austin* Carlos Caldas, UT Engineering* Gil Alterovitz, Harvard Medical School* Kayo Fujimoto, UT Health Houston* Lei Zhang, University of Glasglow* Sean Manion, CSciO of ConsenSys Health* Vijayakuman Varadarajan, University of South Wales* Vikram Dhillon, Wayne State University* Yuichi Ikeda, Kyoto University
PDF